Literature DB >> 27633042

RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.

Bo Ram Kim1, Myoung Hee Kang2, Jung Lim Kim3, Yoo Jin Na1, Seong Hye Park1, Sun Il Lee4, Sanghee Kang4, Sung Yup Joung4, Suk-Young Lee3, Dae-Hee Lee1, Byung Wook Min4, Sang Cheul Oh1.   

Abstract

Recent studies have determined that inactivation of runt‑related transcription factor 3 (RUNX3) expression is highly associated with lymph node metastasis and poor prognosis in various types of cancer. However, the mechanism of RUNX3-mediated suppression of tumor metastasis remains unclear. Herein, we aimed to clarify the effect of RUNX3 on metastasis and angiogenesis in colorectal cancer (CRC). Firstly, we found that the reduction in expression of RUNX3 in CRC tissues when compared with tumor adjacent normal colon tissues, as indicated by reduced RUNX3 staining, was significantly correlated with tumor-node-metastasis (TNM) stage. Secondly, we demonstrated that RUNX3 overexpression inhibited CRC cell migration and invasion resulting from the upregulation of matrix metalloproteinase-2 (MMP-2) and MMP-9 expression. In contrast, the knockdown of RUNX3 reduced the inhibition of migration and invasion of CRC cells. Finally, we found that restoration of RUNX3 decreased vascular endothelial growth factor (VEGF) secretion and suppressed endothelial cell growth and tube formation in CRC cells. All in all, our findings may provide insight into the development of RUNX3 for CRC metastasis diagnostics and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27633042     DOI: 10.3892/or.2016.5086

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer.

Authors:  Bo Ram Kim; Seong Hye Park; Yoon A Jeong; Yoo Jin Na; Jung Lim Kim; Min Jee Jo; Soyeon Jeong; Hye Kyeong Yun; Sang Cheul Oh; Dae-Hee Lee
Journal:  Oncogene       Date:  2019-01-28       Impact factor: 9.867

2.  RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer.

Authors:  Bo Ram Kim; Yoo Jin Na; Jung Lim Kim; Yoon A Jeong; Seong Hye Park; Min Jee Jo; Soyeon Jeong; Sanghee Kang; Sang Cheul Oh; Dae-Hee Lee
Journal:  Cell Death Differ       Date:  2019-07-05       Impact factor: 15.828

3.  RUNX3-regulated circRNA METTL3 inhibits colorectal cancer proliferation and metastasis via miR-107/PER3 axis.

Authors:  Feng Zhang; Tao Su; Meifang Xiao
Journal:  Cell Death Dis       Date:  2022-06-16       Impact factor: 9.685

4.  RUNX3 is up-regulated in abdominal aortic aneurysm and regulates the function of vascular smooth muscle cells by regulating TGF-β1.

Authors:  Zhongxiao Zhou; Haimeng Zhou; Xin Zou; Xiaowei Wang
Journal:  J Mol Histol       Date:  2021-11-23       Impact factor: 3.156

5.  Regulation of RUNX3 Expression by DNA Methylation in Prostate Cancer.

Authors:  Xin Yang; Shumei Wang; Alimu Reheman
Journal:  Cancer Manag Res       Date:  2020-07-27       Impact factor: 3.989

Review 6.  Emerging role of RUNX3 in the regulation of tumor microenvironment.

Authors:  Sarala Manandhar; You Mie Lee
Journal:  BMB Rep       Date:  2018-04       Impact factor: 4.778

7.  Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.

Authors:  Wei-Na Zhou; Yi-Fei Du; Yang Zheng; Wei Zhang; Yu-Nong Wu; Xiao-Meng Song; Jin Bai
Journal:  Mol Med Rep       Date:  2018-11-29       Impact factor: 2.952

8.  RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9.

Authors:  Jun Xue; Xueliang Wu; Ming Qu; Fei Guo; Lei Han; Guangyuan Sun; Zelong Yuan; Shuang Fan; Tian Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.